• “The Dell Technologies Capital team understands both the business potential of genomics processing, and importantly, how ultra-rapid data analysis advances healthcare and potentially saves lives. As a Dell Technologies Capital portfolio company, we were able to utilize Dell Technologies’ ecosystem to collaborate and combine the powerful Dell EMC and Virtustream portfolio with the speed and accuracy of the DRAGEN processor to offer a complete, cost-effective solution for rapid genomic analysis to both of our customers.”

    PIETER VAN ROOYEN, PH.D., CHIEF EXECUTIVE OFFICER OF EDICO GENOME